WE CARE SDOH System for Chronic Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if the WE CARE social determinants of health (SDOH) system can reduce chronic diseases by focusing on health equity for racial and ethnic minorities. It will test whether this approach improves conditions such as high blood pressure, diabetes, depression, high cholesterol, and asthma. The trial compares the WE CARE system with usual care methods to assess its effectiveness. Suitable participants include those with ongoing issues like asthma, diabetes, hypertension, high cholesterol, or depression who receive care at one of the study locations. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research focused on health equity and chronic disease management.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on social determinants of health rather than medication changes.
What prior data suggests that the WE CARE SDOH System is safe for use in primary care settings?
Research has shown that the WE CARE SDOH System targets social factors affecting health, such as living and working conditions. This system aids in managing chronic conditions like high blood pressure, diabetes, and asthma.
Studies have found that the WE CARE system can be effectively implemented in busy healthcare settings. It involves screening and referrals to identify and address social issues impacting health.
The sources provided report no negative effects from using the WE CARE SDOH System. Since this trial does not involve a new drug or invasive treatment but rather a screening and referral process, it is generally considered safe for participants. The trial aims to evaluate its effectiveness in reducing health disparities.12345Why are researchers excited about this trial?
Researchers are excited about the WE CARE SDOH System because it aims to integrate social determinants of health (SDOH) into chronic disease management, which is a relatively new approach. Unlike traditional treatments that focus solely on medical interventions, the WE CARE System collaborates with clinic staff to address factors like access to healthy food, housing stability, and social support. By tackling these broader issues, the system hopes to improve patient outcomes in ways that current treatments might not fully achieve. This comprehensive approach has the potential to revolutionize how chronic diseases are managed by considering the whole patient, not just their symptoms.
What evidence suggests that the WE CARE SDOH System is effective for reducing chronic diseases?
Research has shown that addressing social factors affecting health can improve conditions like high blood pressure, diabetes, and asthma. This trial implements the WE CARE SDOH System to identify and address social needs, such as access to food and housing, linked to these health issues. A review of studies has found that incorporating these social factors into healthcare can provide significant health benefits. By reducing social obstacles, the WE CARE approach aims to lessen health disparities among racial and ethnic minorities. Studies have demonstrated that these efforts can lead to better management of chronic diseases.26789
Are You a Good Fit for This Trial?
The WE CARE Chronic Disease Study is for individuals with chronic conditions like high cholesterol, diabetes, childhood asthma, high blood pressure, or depression. It's designed to see if a new health screening and referral system can help reduce these issues and improve overall care.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Qualitative Interviews
Conduct qualitative interviews with adult patients and caregivers to understand their experiences with racism and discrimination within the context of their experiences with screening and referral for SDOH.
Implementation
Implement the refined WE CARE protocol in family medicine clinics to assess its impact on improving health outcomes for racialized groups.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- WE CARE SDOH System
Trial Overview
This trial tests the 'WE CARE SDOH System', which screens for social factors affecting health and provides referrals as needed. It will be compared to standard pediatric care to see if it better manages chronic diseases while addressing racial/ethnic health disparities.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
The study team will work with clinic staff and leadership to implement the WE CARE protocol at each clinical site.
Participants in the usual care group receive standard pediatric care. In this study, participants in the Usual Care arm are a historical cohort of patients who meet eligibility criteria and are identified retrospectively from the Electronic Health Records. As such the investigators have registered this study on Clinical Trial.gov prior to the implementation of the active WE CARE experimental arm.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Massachusetts, Worcester
Lead Sponsor
Family Health Center of Worcester
Collaborator
Boston Medical Center
Collaborator
Boston University
Collaborator
National Institute of Nursing Research (NINR)
Collaborator
Published Research Related to This Trial
Citations
Social Needs Screening and Chronic Diseases Study (WE ...
The goal of this clinical trial is to learn if the implementation of the WE CARE social determinants of health (SDOH) screening and referral intervention ...
WE CARE SDOH System for Chronic Disease
What data supports the effectiveness of the WE CARE SDOH System treatment for chronic disease? The research highlights the importance of improving chronic ...
Effectiveness of Social Needs Screening and Interventions in ...
This systematic review examined and synthesized peer-reviewed research studies that reported the process of integrating social determinants of health (SDOH) or ...
Trends in Multiple Chronic Conditions Among US Adults ...
In 2023, 76.4% (representing 194 million) of US adults reported 1 or more chronic conditions, including 59.5%, 78.4%, and 93.0% of young, midlife, and older ...
Addressing adverse social determinants of health in ...
This hybrid type 2 effectiveness-implementation trial aims to demonstrate the non-inferiority of a low-touch implementation strategy.
Universal Screening for Social Determinants of Health in ...
The aims of this study were to determine the feasibility of universal screening for SDoH in a busy subspeciality clinic using pre-existing resources.
WE CARE
WE CARE screening tool was developed by Arvin Garg, MD, MPH to test a family-centered system to address adverse social determinants of health.
The WE CARE Model
WE CARE is a social determinants of health (SDoH) screening and referral intervention. SDoH are the social circumstances in which people are born, work, live, ...
Social Determinants of Health and Health-Related ...
We sought to determine relationships between SDOH/HRSN and major chronic diseases among US adults by using data from the 2022 Behavioral Risk ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.